Prothrombinex®‐VF in chronic liver disease: Friend or foe?

OBJECTIVE: Management of coagulopathy in chronic liver disease (CLD) poses a challenge for critical care physicians. Prothrombinex®‐VF is a low‐volume product with rapid onset of action. Evidence for its efficacy and safety in CLD is limited and cases of acute intravascular coagulation and fibrinoly...

Descripción completa

Detalles Bibliográficos
Autores principales: Latona, Akmez, Hill, Kate, Connelly, Aurelia, Stuart, Katherine, Wood, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087488/
https://www.ncbi.nlm.nih.gov/pubmed/35993256
http://dx.doi.org/10.1111/1742-6723.14058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087488/
https://www.ncbi.nlm.nih.gov/pubmed/35993256
http://dx.doi.org/10.1111/1742-6723.14058

Ejemplares similares